Story
Bristol Myers Squibb to Build $2.3 Billion Manufacturing Plant in Houston

Bristol Myers Squibb on Monday announced plans to invest approximately $2.3 billion to construct a new manufacturing facility in Houston, Texas. The project is part of a previously declared $40 billion commitment to U.S. investments by the pharmaceutical giant and is expected to significantly expand its domestic production capacity.
Investment and Job Creation
The New Jersey-based company stated that the new site will create nearly 500 skilled, full-time jobs. The construction phase, slated to run from 2027 to 2030, is projected to generate an additional 2,000 temporary jobs in construction and related fields.
In a statement, Texas Governor Greg Abbott confirmed the state's support for the project, which includes a $4.89 million grant from the Texas Enterprise Fund. The facility also qualifies for benefits under the state’s Jobs, Energy, Technology and Innovation (JETI) program.
Facility Capabilities
AdThe planned campus will span roughly 600,000 square feet and is being designed for advanced manufacturing. According to Bristol Myers, the site will be equipped to produce a range of medicines, including small-molecule therapies as well as more complex treatments like biologics and antibody-drug conjugates.
The company emphasized that the facility will be built with flexibility in mind, allowing it to be reconfigured or expanded to meet the evolving needs of its drug pipeline. "This investment reflects our confidence in America’s continued leadership in biopharmaceutical innovation," said Chief Executive Christopher Boerner in a statement.
Industry Context
This announcement aligns with a broader trend among major pharmaceutical companies, including Pfizer, Eli Lilly, and Johnson & Johnson, to increase their manufacturing footprint within the United States. The move by Bristol Myers is a significant step in onshoring the production of critical medicines, a focus for the industry following pressure from the Trump administration to bolster domestic supply chains.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.